[{"id":"bb69efe9-45ed-49ff-b5d3-eaf8dde103f6","acronym":"PBroC","url":"https://clinicaltrials.gov/study/NCT01265953","created_at":"2021-03-30T16:52:09.200Z","updated_at":"2024-07-02T16:36:59.975Z","phase":"","brief_title":"Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation","source_id_and_acronym":"NCT01265953 - PBroC","lead_sponsor":"Portland VA Medical Center","biomarkers":" HDAC6","pipe":" | ","alterations":" HDAC6 expression","tags":["HDAC6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HDAC6 expression"],"overall_status":"Completed","enrollment":" Enrollment 98","initiation":"Initiation: 07/01/2011","start_date":" 07/01/2011","primary_txt":" Primary completion: 10/01/2015","primary_completion_date":" 10/01/2015","study_txt":" Completion: 12/01/2015","study_completion_date":" 12/01/2015","last_update_posted":"2019-05-01"},{"id":"ac02c06d-b177-4fba-9873-0c26d5aba54f","acronym":"","url":"https://clinicaltrials.gov/study/NCT00788112","created_at":"2021-01-18T02:59:08.892Z","updated_at":"2024-07-02T16:37:19.139Z","phase":"Phase 1","brief_title":"Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast","source_id_and_acronym":"NCT00788112","lead_sponsor":"University of California, San Francisco","biomarkers":" HDAC6 • HDAC1","pipe":" | ","alterations":" HDAC6 expression","tags":["HDAC6 • HDAC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HDAC6 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Zolinza (vorinostat)"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 07/01/2009","start_date":" 07/01/2009","primary_txt":" Primary completion: 11/03/2011","primary_completion_date":" 11/03/2011","study_txt":" Completion: 08/11/2015","study_completion_date":" 08/11/2015","last_update_posted":"2017-08-07"}]